HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SKB BIO

497.200

-17.300-3.36%

Volume:1.23M

Turnover:609.66M

Market Cap:118.83B

PE:-257.18

High:507.000

Open:493.600

Low:485.200

Close:514.500

52wk High:581.000

52wk Low:339.600

Shares:239.00M

HK Float Shares:177.00M

Volume Ratio:2.03

T/O Rate:0.70%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.933

ROE:2.92%

ROA:0.03%

PB:19.08

PE(LYR):-257.18

PS:48.82

Loading ...

Overview Company News Filings

Movement Alert｜Kelun-Biotech Biopharmaceutical Rises 3.07% in Regular Trading, Nomura Raises Target Price to HK$544.42 on Encouraging Phase III ADC Data

Movement Alert｜Kelun-Biotech Biopharmaceutical Rises 3.12% in Regular Trading, ASCO Annual Meeting Data Continues to Catalyze Pipeline Value Reassessment

Kelun Biotech to Present Study Results of Cancer Drugs at American Oncology Meeting

MT Newswires Live

SKB BIO Receives "Buy" Rating from China Post Securities on Anticipated Global Pipeline Value Realization

BUZZ-Sichuan Kelun-Biotech at 4-week high on positive lung cancer trial with Merck

Movement Alert｜Kelun-Biotech Biopharmaceutical Rises 7.58% in Regular Trading, ASCO Oral Presentations and Phase III Lung Cancer Trial Success Drive Momentum

Stock Track | SKB BIO Soars 5.16% at Open on Positive Phase III Lung Cancer Data and ASCO Presentation News

Movement Alert｜Kelun-Biotech Biopharmaceutical Rises 5.34% at Open, ASCO Oral Presentations and Multiple Phase III Successes Drive Momentum

SKB BIO Highlights Robust Sac-TMT Phase III and Lunbotinib Phase II Data Ahead of ASCO 2026

Bulletin Express

SKB BIO (06990) to Present Multiple Innovative Drug Research Findings at 2026 ASCO Annual Meeting

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd - Nda for Lunbotinib Fumarate Accepted for Review by Nmpa

THOMSON REUTERS

BRIEF-Kelun-Biotech's Sac-TMT + Pembrolizumab Improves Survival In Late-Stage China Trial

Sichuan Kelun-Biotech Biopharmaceutical: Sacituzumab Tirumotecan + Pembrolizumab Extended Pfs VS Pembrolizumab Alone in Phase 3 Lung Cancer Trial

THOMSON REUTERS

Sichuan Kelun-Biotech Biopharmaceutical-Safety Profile of Sac-TMT + Pembrolizumab Generally Manageable, Consistent With Safety Profile of Components

THOMSON REUTERS

Kelun, Merck's lung cancer combo improves survival in late-stage China trial

Kelun-Biotech says sac-TMT beats chemotherapy in Phase III first-line TNBC PFS

SKB BIO Shares Surge Over 5% on Positive Phase III Results for TROP2 ADC Developed with Merck

Stock Track | SKB BIO Soars 5.22% Intraday on Positive Phase III Trial Results and Regulatory Approval

Movement Alert｜Kelun-Biotech Biopharmaceutical Rises 3.52% in Regular Trading, TROP2 ADC Phase III Trial Achieves Dual Primary Endpoints in Endometrial Cancer

A Look At Sichuan Kelun-Biotech Biopharmaceutical’s (SEHK:6990) Valuation After New Oncology Regulatory Milestones

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/06990/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06990","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"SKB BIO","latestPrice":497.2,"timestamp":1788163728010,"preClose":514.5,"halted":0,"volume":1232718,"delay":0,"changeRate":-0.03362487852283773,"floatShares":177000000,"shares":239000000,"eps":-1.9332648768940135,"marketStatus":"Not Yet Opened","change":-17.3,"latestTime":"08-31 16:08:48","open":493.6,"high":507,"low":485.2,"amount":609656456,"amplitude":0.042371,"askPrice":497.2,"askSize":52100,"bidPrice":496.4,"bidSize":7100,"shortable":3,"etf":0,"ttmEps":0.7563750203883266,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788226200000},"marketStatusCode":0,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":514.5,"openAndCloseTimeList":[[1788139800000,1788148800000],[1788152400000,1788163200000]],"volumeRatio":2.026951300603982,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","floatShares":177000000,"roa":"0.03%","roe":"2.92%","lyrEps":-1.933265,"volumeRatio":2.026951300603982,"shares":239000000,"dividePrice":0,"high":507,"amplitude":0.042371,"preClose":514.5,"low":485.2,"week52Low":339.6,"pbRate":"19.08","psRate":"48.82","week52High":581,"institutionHeld":0,"latestPrice":497.2,"committee":-0.760135,"eps":-1.9332648768940135,"divideRate":0,"volume":1232718,"delay":0,"ttmEps":0.7563750203883266,"open":493.6,"prevYearClose":392.2,"prevWeekClose":514.5,"prevMonthClose":497.2,"prevQuarterClose":436.2,"fiveDayClose":523,"twentyDayClose":476.8,"sixtyDayClose":390.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06990\",params:#limit:5,,,undefined,":[{"date":"2026-08-17","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786930200000,"name":null,"time":"","dateTimestamp":1786896000000,"actualEps":null},{"market":"HK","date":"2026-03-23","symbol":"06990","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-18","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-24","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"Post-Mkt","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-19","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"Post-Mkt","dateTimestamp":1723996800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06990\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06990\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":21,"updateTime":1786809600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06990\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06990","date":"2026-08-28","current":657.345876,"percent":0.989637,"low":-351.800852,"twenty":-236.422847,"median":-135.694724,"eighty":-52.683151,"high":737.230287,"avg":-131.901495,"sd":123.597476,"marketCap":122977832050},"quantilePoints":[{"date":"2023-07-14","current":-21.13661,"twenty":-21.950454,"median":-21.915957,"eighty":-21.591449,"marketCap":14244687534},{"date":"2023-07-21","current":-23.970152,"twenty":-21.950454,"median":-21.798359,"eighty":-21.186829,"marketCap":16079230625},{"date":"2023-07-28","current":-25.171471,"twenty":-24.928642,"median":-21.953758,"eighty":-21.326081,"marketCap":16867005011},{"date":"2023-08-04","current":-23.795235,"twenty":-24.81024,"median":-23.425444,"eighty":-21.637654,"marketCap":15971316326},{"date":"2023-08-11","current":-25.354634,"twenty":-24.81024,"median":-23.323535,"eighty":-21.856149,"marketCap":16921892522},{"date":"2023-08-18","current":-27.290696,"twenty":-25.136334,"median":-23.811022,"eighty":-21.920213,"marketCap":18083628667},{"date":"2023-08-25","current":-27.955027,"twenty":-25.91111,"median":-24.066367,"eighty":-21.957062,"marketCap":18532979440},{"date":"2023-09-01","current":-41.23344,"twenty":-27.36684,"median":-24.766756,"eighty":-21.989236,"marketCap":16768455673},{"date":"2023-09-08","current":-41.179226,"twenty":-40.625811,"median":-24.994187,"eighty":-22.159386,"marketCap":16549260174},{"date":"2023-09-15","current":-42.756679,"twenty":-41.200358,"median":-25.354634,"eighty":-22.761005,"marketCap":17316444421},{"date":"2023-09-22","current":-42.808543,"twenty":-42.12743,"median":-25.915972,"eighty":-23.169807,"marketCap":17261645546},{"date":"2023-09-29","current":-41.568511,"twenty":-42.347449,"median":-27.197776,"eighty":-23.343916,"marketCap":16790375223},{"date":"2023-10-06","current":-41.914184,"twenty":-42.346401,"median":-27.481057,"eighty":-23.57336,"marketCap":16921892522},{"date":"2023-10-13","current":-45.021843,"twenty":-42.393899,"median":-34.166325,"eighty":-23.80155,"marketCap":18149387317},{"date":"2023-10-20","current":-39.509362,"twenty":-42.529229,"median":-40.304828,"eighty":-23.874674,"marketCap":15902633452},{"date":"2023-10-27","current":-41.923505,"twenty":-42.45246,"median":-40.317099,"eighty":-23.977981,"marketCap":16867093648},{"date":"2023-11-03","current":-44.17615,"twenty":-43.157759,"median":-40.968576,"eighty":-24.032126,"marketCap":17820594068},{"date":"2023-11-10","current":-48.451746,"twenty":-43.729096,"median":-41.213927,"eighty":-24.147781,"marketCap":19541278735},{"date":"2023-11-17","current":-48.422639,"twenty":-44.163404,"median":-41.246315,"eighty":-24.349478,"marketCap":19705675360},{"date":"2023-11-24","current":-47.973827,"twenty":-44.628759,"median":-41.529173,"eighty":-24.780872,"marketCap":19683755810},{"date":"2023-12-01","current":-50.941262,"twenty":-45.174782,"median":-41.90853,"eighty":-24.844962,"marketCap":20987969029},{"date":"2023-12-08","current":-50.880899,"twenty":-46.685504,"median":-41.9817,"eighty":-24.922954,"marketCap":20878371279},{"date":"2023-12-15","current":-53.058458,"twenty":-47.438439,"median":-42.172758,"eighty":-25.124621,"marketCap":21897630350},{"date":"2023-12-22","current":-55.272951,"twenty":-48.26932,"median":-42.355666,"eighty":-25.208104,"marketCap":22796331896},{"date":"2023-12-29","current":-54.398289,"twenty":-48.483234,"median":-42.389893,"eighty":-25.318001,"marketCap":22555216847},{"date":"2024-01-05","current":-54.305497,"twenty":-48.692055,"median":-42.518207,"eighty":-25.505631,"marketCap":22357940898},{"date":"2024-01-12","current":-58.852865,"twenty":-49.706536,"median":-42.808543,"eighty":-25.777515,"marketCap":24243022189},{"date":"2024-01-19","current":-48.649703,"twenty":-50.614438,"median":-43.44751,"eighty":-25.920835,"marketCap":20012549058},{"date":"2024-01-26","current":-45.202208,"twenty":-50.432693,"median":-43.523908,"eighty":-26.320623,"marketCap":18522019665},{"date":"2024-02-02","current":-38.832469,"twenty":-50.323187,"median":-43.65215,"eighty":-26.948338,"marketCap":15891673677},{"date":"2024-02-09","current":-43.972121,"twenty":-49.706536,"median":-43.780393,"eighty":-27.253528,"marketCap":18083628667},{"date":"2024-02-16","current":-51.156498,"twenty":-50.095577,"median":-43.99523,"eighty":-27.328768,"marketCap":21042767904},{"date":"2024-02-23","current":-57.052501,"twenty":-50.855188,"median":-44.095348,"eighty":-27.575851,"marketCap":23344320643},{"date":"2024-03-01","current":-55.517903,"twenty":-51.144997,"median":-44.174132,"eighty":-27.979787,"marketCap":22730573246},{"date":"2024-03-08","current":-62.556972,"twenty":-52.587613,"median":-44.308071,"eighty":-30.229554,"marketCap":25623953833},{"date":"2024-03-15","current":-80.340969,"twenty":-54.14227,"median":-44.794506,"eighty":-38.844663,"marketCap":32879324850},{"date":"2024-03-22","current":-87.812662,"twenty":-54.39157,"median":-45.089055,"eighty":-38.957109,"marketCap":35904222736},{"date":"2024-03-28","current":-54.646477,"twenty":-54.498503,"median":-45.202208,"eighty":-39.211798,"marketCap":33975302345},{"date":"2024-04-05","current":-48.790889,"twenty":-54.557693,"median":-45.399289,"eighty":-39.390336,"marketCap":30314737511},{"date":"2024-04-12","current":-51.407626,"twenty":-54.48688,"median":-46.006494,"eighty":-39.95604,"marketCap":31958703754},{"date":"2024-04-19","current":-48.134373,"twenty":-54.430626,"median":-46.386128,"eighty":-40.284427,"marketCap":29898266063},{"date":"2024-04-26","current":-71.709655,"twenty":-54.881886,"median":-46.751052,"eighty":-40.312191,"marketCap":36824843832},{"date":"2024-05-03","current":-70.050704,"twenty":-55.277405,"median":-46.894686,"eighty":-40.440284,"marketCap":35948061836},{"date":"2024-05-10","current":-80.537958,"twenty":-55.535893,"median":-47.299854,"eighty":-40.706984,"marketCap":41427949311},{"date":"2024-05-17","current":-72.846762,"twenty":-56.640749,"median":-47.434905,"eighty":-40.885351,"marketCap":37416671679},{"date":"2024-05-24","current":-76.490072,"twenty":-57.838988,"median":-47.480121,"eighty":-41.121673,"marketCap":39198277014},{"date":"2024-05-31","current":-74.804992,"twenty":-59.45269,"median":-48.0541,"eighty":-41.186166,"marketCap":38373753847},{"date":"2024-06-07","current":-77.551054,"twenty":-62.567703,"median":-48.422639,"eighty":-41.217553,"marketCap":39733102851},{"date":"2024-06-14","current":-71.048454,"twenty":-63.220056,"median":-48.609184,"eighty":-41.232055,"marketCap":36368156956},{"date":"2024-06-21","current":-75.38559,"twenty":-65.709636,"median":-48.654461,"eighty":-41.23344,"marketCap":38507460307},{"date":"2024-06-28","current":-72.361795,"twenty":-70.050704,"median":-48.790889,"eighty":-41.25919,"marketCap":36947551614},{"date":"2024-07-05","current":-71.32983,"twenty":-70.110492,"median":-48.913989,"eighty":-41.293743,"marketCap":36412725776},{"date":"2024-07-12","current":-64.338068,"twenty":-69.786991,"median":-49.290918,"eighty":-41.483815,"marketCap":32891789012},{"date":"2024-07-19","current":-64.816339,"twenty":-69.10708,"median":-50.290098,"eighty":-41.560643,"marketCap":33136917521},{"date":"2024-07-26","current":-64.836994,"twenty":-68.943217,"median":-50.396598,"eighty":-41.836002,"marketCap":33270623980},{"date":"2024-08-02","current":-67.177788,"twenty":-68.832021,"median":-50.583009,"eighty":-41.911922,"marketCap":34451697705},{"date":"2024-08-09","current":-67.337335,"twenty":-68.832021,"median":-50.91108,"eighty":-41.921641,"marketCap":34763679444},{"date":"2024-08-16","current":-69.468586,"twenty":-68.832021,"median":-51.098991,"eighty":-41.970061,"marketCap":35877899939},{"date":"2024-08-23","current":-143.952492,"twenty":-69.519081,"median":-51.282062,"eighty":-42.023931,"marketCap":36568716645},{"date":"2024-08-30","current":-142.905377,"twenty":-70.543671,"median":-51.775379,"eighty":-42.069838,"marketCap":36546432236},{"date":"2024-09-06","current":-147.713941,"twenty":-71.622574,"median":-52.451442,"eighty":-42.229208,"marketCap":37794359190},{"date":"2024-09-13","current":-159.71572,"twenty":-72.235174,"median":-53.058458,"eighty":-42.319371,"marketCap":40758185707},{"date":"2024-09-20","current":-153.295015,"twenty":-72.624329,"median":-53.663008,"eighty":-42.346401,"marketCap":39354267883},{"date":"2024-09-27","current":-152.378595,"twenty":-73.54444,"median":-54.299669,"eighty":-42.364187,"marketCap":39354267883},{"date":"2024-10-04","current":-188.785359,"twenty":-74.133327,"median":-54.381491,"eighty":-42.385888,"marketCap":48535444762},{"date":"2024-10-10","current":-168.292174,"twenty":-74.96999,"median":-54.488817,"eighty":-42.420555,"marketCap":42986626697},{"date":"2024-10-18","current":-169.261982,"twenty":-75.395206,"median":-54.742682,"eighty":-42.48514,"marketCap":43008911107},{"date":"2024-10-25","current":-173.131782,"twenty":-76.300948,"median":-55.181976,"eighty":-42.60999,"marketCap":43989425142},{"date":"2024-11-01","current":-155.135166,"twenty":-77.964709,"median":-55.298647,"eighty":-42.767052,"marketCap":39443405523},{"date":"2024-11-08","current":-154.553256,"twenty":-78.843611,"median":-55.532894,"eighty":-42.819467,"marketCap":38997717325},{"date":"2024-11-15","current":-143.716763,"twenty":-80.792913,"median":-56.569783,"eighty":-42.897746,"marketCap":35989321988},{"date":"2024-11-22","current":-149.571879,"twenty":-86.542136,"median":-57.071537,"eighty":-43.077872,"marketCap":37437808632},{"date":"2024-11-29","current":-163.214034,"twenty":-139.660525,"median":-57.926605,"eighty":-43.27892,"marketCap":40825038936},{"date":"2024-12-06","current":-164.492389,"twenty":-143.07608,"median":-58.601892,"eighty":-43.427612,"marketCap":41047883035},{"date":"2024-12-13","current":-167.859925,"twenty":-143.961595,"median":-59.46824,"eighty":-43.489321,"marketCap":41805552972},{"date":"2024-12-20","current":-160.518216,"twenty":-146.054141,"median":-61.493522,"eighty":-43.569737,"marketCap":39799956081},{"date":"2024-12-27","current":-154.616488,"twenty":-147.398806,"median":-62.556972,"eighty":-43.707223,"marketCap":38306900618},{"date":"2025-01-03","current":-146.467928,"twenty":-147.580179,"median":-62.909234,"eighty":-43.769457,"marketCap":36323588137},{"date":"2025-01-10","current":-149.189796,"twenty":-147.713941,"median":-63.270129,"eighty":-43.89543,"marketCap":36858413974},{"date":"2025-01-17","current":-146.545949,"twenty":-148.128618,"median":-63.821936,"eighty":-43.999852,"marketCap":36234450497},{"date":"2025-01-24","current":-151.096908,"twenty":-148.795989,"median":-64.223738,"eighty":-44.022873,"marketCap":37593799501},{"date":"2025-01-28","current":-144.751587,"twenty":-148.750633,"median":-64.3181,"eighty":-44.025895,"marketCap":36203787461},{"date":"2025-02-07","current":-162.755483,"twenty":-148.864023,"median":-64.816339,"eighty":-44.095348,"marketCap":40476425278},{"date":"2025-02-14","current":-166.856795,"twenty":-150.654332,"median":-65.202788,"eighty":-44.112421,"marketCap":41476404342},{"date":"2025-02-21","current":-194.414734,"twenty":-151.676932,"median":-65.382992,"eighty":-44.172115,"marketCap":48498984584},{"date":"2025-02-28","current":-211.14481,"twenty":-152.24965,"median":-65.712478,"eighty":-44.17615,"marketCap":52498900839},{"date":"2025-03-07","current":-225.41295,"twenty":-152.905086,"median":-66.309677,"eighty":-44.219461,"marketCap":56271549124},{"date":"2025-03-14","current":-227.151092,"twenty":-153.295015,"median":-66.812487,"eighty":-44.308071,"marketCap":56726085062},{"date":"2025-03-21","current":-236.708664,"twenty":-154.553256,"median":-67.337335,"eighty":-44.550078,"marketCap":59089671940},{"date":"2025-03-28","current":-231.805328,"twenty":-155.61149,"median":-67.803663,"eighty":-44.648429,"marketCap":66180441600},{"date":"2025-04-03","current":-246.46154,"twenty":-156.727441,"median":-67.952396,"eighty":-44.882152,"marketCap":70225812000},{"date":"2025-04-11","current":-242.489155,"twenty":-158.779779,"median":-68.515098,"eighty":-45.005591,"marketCap":68634936000},{"date":"2025-04-17","current":-228.611836,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"marketCap":64862287200},{"date":"2025-04-25","current":-235.137362,"twenty":-160.624501,"median":-68.953584,"eighty":-45.131919,"marketCap":66771338400},{"date":"2025-05-02","current":-274.570331,"twenty":-161.195254,"median":-69.468586,"eighty":-45.197413,"marketCap":78134738400},{"date":"2025-05-09","current":-249.374354,"twenty":-161.514906,"median":-70.050704,"eighty":-45.202208,"marketCap":71462875059},{"date":"2025-05-16","current":-247.507619,"twenty":-162.87029,"median":-70.732965,"eighty":-45.217068,"marketCap":71507400214},{"date":"2025-05-23","current":-244.618313,"twenty":-163.824551,"median":-71.32983,"eighty":-45.58151,"marketCap":70884048033},{"date":"2025-05-30","current":-244.159494,"twenty":-165.025774,"median":-71.669987,"eighty":-45.601984,"marketCap":71062148656},{"date":"2025-06-06","current":-258.187076,"twenty":-166.004403,"median":-72.203519,"eighty":-46.006494,"marketCap":75336563613},{"date":"2025-06-13","current":-271.678883,"twenty":-167.701589,"median":-72.488214,"eighty":-46.133909,"marketCap":79304691313},{"date":"2025-06-20","current":-252.757485,"twenty":-168.349452,"median":-72.789206,"eighty":-46.315126,"marketCap":73636805593},{"date":"2025-06-27","current":-255.806605,"twenty":-169.647858,"median":-73.569836,"eighty":-46.457129,"marketCap":74733815733},{"date":"2025-07-04","current":-283.173205,"twenty":-171.495185,"median":-73.869687,"eighty":-46.685504,"marketCap":82732847998},{"date":"2025-07-11","current":-266.231967,"twenty":-173.142078,"median":-74.539848,"eighty":-46.749361,"marketCap":77704884860},{"date":"2025-07-18","current":-304.526119,"twenty":-187.755426,"median":-75.01675,"eighty":-46.798833,"marketCap":88812112519},{"date":"2025-07-25","current":-289.211949,"twenty":-196.095673,"median":-75.38559,"eighty":-46.877904,"marketCap":84652615741},{"date":"2025-08-01","current":-318.351212,"twenty":-209.071662,"median":-75.715906,"eighty":-46.908544,"marketCap":92605939250},{"date":"2025-08-08","current":-315.832709,"twenty":-214.487876,"median":-76.34536,"eighty":-47.149906,"marketCap":92103142937},{"date":"2025-08-15","current":-340.637946,"twenty":-221.73884,"median":-77.157567,"eighty":-47.354138,"marketCap":99188000086},{"date":"2025-08-22","current":-135.707825,"twenty":-221.73884,"median":-78.335478,"eighty":-47.421279,"marketCap":106638527281},{"date":"2025-08-29","current":-131.473703,"twenty":-217.466422,"median":-78.819337,"eighty":-47.438439,"marketCap":103804584421},{"date":"2025-09-05","current":-151.82862,"twenty":-215.82299,"median":-80.340969,"eighty":-47.449348,"marketCap":119756940196},{"date":"2025-09-12","current":-146.494298,"twenty":-214.791029,"median":-81.555855,"eighty":-47.474394,"marketCap":115757424063},{"date":"2025-09-19","current":-147.466634,"twenty":-214.487876,"median":-85.53437,"eighty":-47.73502,"marketCap":116443055400},{"date":"2025-09-26","current":-143.954691,"twenty":-214.295448,"median":-89.950081,"eighty":-47.938811,"marketCap":113375018127},{"date":"2025-10-03","current":-165.853778,"twenty":-213.463042,"median":-128.34687,"eighty":-48.070155,"marketCap":130933921593},{"date":"2025-10-10","current":-144.531455,"twenty":-212.219938,"median":-131.729362,"eighty":-48.217901,"marketCap":113934664453},{"date":"2025-10-17","current":-135.703716,"twenty":-210.108236,"median":-132.867642,"eighty":-48.374971,"marketCap":106892448189},{"date":"2025-10-24","current":-129.499037,"twenty":-207.014216,"median":-133.546653,"eighty":-48.434282,"marketCap":102042180034},{"date":"2025-10-31","current":-132.379263,"twenty":-204.550971,"median":-132.326202,"eighty":-48.483234,"marketCap":104467314112},{"date":"2025-11-07","current":-120.930715,"twenty":-203.710245,"median":-131.985022,"eighty":-48.610423,"marketCap":95373061321},{"date":"2025-11-14","current":-137.099974,"twenty":-201.138492,"median":-131.729362,"eighty":-48.622244,"marketCap":108431475585},{"date":"2025-11-21","current":-125.836792,"twenty":-194.360264,"median":-130.233026,"eighty":-48.651606,"marketCap":99477134375},{"date":"2025-11-28","current":-134.139839,"twenty":-194.090443,"median":-131.64896,"eighty":-48.675637,"marketCap":106426076251},{"date":"2025-12-05","current":-134.965867,"twenty":-192.863217,"median":-131.473703,"eighty":-48.751223,"marketCap":107265545740},{"date":"2025-12-12","current":-128.449432,"twenty":-188.527876,"median":-130.526276,"eighty":-48.814858,"marketCap":102275366003},{"date":"2025-12-19","current":-122.479247,"twenty":-187.446049,"median":-129.499037,"eighty":-48.911385,"marketCap":97751558204},{"date":"2025-12-24","current":-122.098928,"twenty":-187.290368,"median":-128.758533,"eighty":-48.913338,"marketCap":97751558204},{"date":"2026-01-02","current":-116.223952,"twenty":-179.729041,"median":-128.478737,"eighty":-49.104524,"marketCap":93414299181},{"date":"2026-01-09","current":-137.872108,"twenty":-173.799059,"median":-128.508043,"eighty":-49.251224,"marketCap":111089795631},{"date":"2026-01-16","current":-136.67551,"twenty":-173.152374,"median":-129.252083,"eighty":-49.296233,"marketCap":110483512112},{"date":"2026-01-23","current":-124.044288,"twenty":-172.874196,"median":-128.511935,"eighty":-49.590244,"marketCap":100176692282},{"date":"2026-01-30","current":-119.398299,"twenty":-172.654145,"median":-128.43808,"eighty":-50.08289,"marketCap":96865451522},{"date":"2026-02-06","current":-121.3325,"twenty":-172.20913,"median":-127.906249,"eighty":-50.304899,"marketCap":98684302080},{"date":"2026-02-13","current":-119.328264,"twenty":-171.604872,"median":-127.229577,"eighty":-50.349599,"marketCap":97611646623},{"date":"2026-02-20","current":-118.929435,"twenty":-171.385498,"median":-126.777731,"eighty":-50.372821,"marketCap":97145274685},{"date":"2026-02-27","current":-109.393801,"twenty":-170.608939,"median":-126.362178,"eighty":-50.420375,"marketCap":90336244390},{"date":"2026-03-06","current":-109.941252,"twenty":-169.952459,"median":-125.237252,"eighty":-50.5225,"marketCap":90056421227},{"date":"2026-03-13","current":-111.874188,"twenty":-169.826622,"median":-125.028422,"eighty":-50.583009,"marketCap":92061820561},{"date":"2026-03-20","current":-118.784792,"twenty":-169.647858,"median":-124.510593,"eighty":-50.752344,"marketCap":97378460654},{"date":"2026-03-27","current":-246.717525,"twenty":-170.608939,"median":-124.791344,"eighty":-50.880899,"marketCap":106705913600},{"date":"2026-04-02","current":-270.1664,"twenty":-172.638036,"median":-125.053164,"eighty":-50.929189,"marketCap":117409151000},{"date":"2026-04-10","current":-262.507699,"twenty":-173.162671,"median":-125.237252,"eighty":-50.974222,"marketCap":114960698000},{"date":"2026-04-17","current":-276.768173,"twenty":-188.270393,"median":-126.362178,"eighty":-51.053793,"marketCap":121256720000},{"date":"2026-04-24","current":-263.25072,"twenty":-199.457552,"median":-126.777731,"eighty":-51.109685,"marketCap":115341038016},{"date":"2026-04-30","current":-249.758244,"twenty":-207.783795,"median":-127.598017,"eighty":-51.131881,"marketCap":109457493848},{"date":"2026-05-08","current":-237.123047,"twenty":-214.424086,"median":-128.140667,"eighty":-51.206724,"marketCap":104280765336},{"date":"2026-05-15","current":-230.895214,"twenty":-220.549694,"median":-128.478737,"eighty":-51.422215,"marketCap":101808994065},{"date":"2026-05-22","current":-251.35436,"twenty":-225.355554,"median":-129.00513,"eighty":-51.539533,"marketCap":110576786499},{"date":"2026-05-29","current":-244.039033,"twenty":-227.151092,"median":-129.499037,"eighty":-51.775379,"marketCap":107731917678},{"date":"2026-06-05","current":-207.501784,"twenty":-227.151092,"median":-130.526276,"eighty":-51.91711,"marketCap":91735360204},{"date":"2026-06-12","current":-219.148588,"twenty":-226.740676,"median":-131.473703,"eighty":-52.267792,"marketCap":96818814328},{"date":"2026-06-18","current":-218.939992,"twenty":-226.404961,"median":-131.824218,"eighty":-52.561632,"marketCap":96958725910},{"date":"2026-06-26","current":-221.178526,"twenty":-225.594566,"median":-132.326202,"eighty":-52.73121,"marketCap":97471735042},{"date":"2026-07-03","current":-263.841103,"twenty":-227.197711,"median":-132.771691,"eighty":-52.93717,"marketCap":116359798531},{"date":"2026-07-10","current":-273.42961,"twenty":-228.864297,"median":-133.50718,"eighty":-53.148078,"marketCap":120440552988},{"date":"2026-07-17","current":-263.005613,"twenty":-229.666754,"median":-134.182751,"eighty":-53.480935,"marketCap":116261258521},{"date":"2026-07-24","current":-277.867014,"twenty":-230.754675,"median":-134.677954,"eighty":-54.022455,"marketCap":122858320066},{"date":"2026-07-31","current":-261.04507,"twenty":-231.704791,"median":-134.965867,"eighty":-54.274788,"marketCap":115639796202},{"date":"2026-08-07","current":-290.535115,"twenty":-235.013451,"median":-135.70577,"eighty":-54.298503,"marketCap":128953431275},{"date":"2026-08-14","current":-279.9487,"twenty":-236.676246,"median":-136.101797,"eighty":-54.329175,"marketCap":124411975864},{"date":"2026-08-21","current":729.337059,"twenty":-236.676246,"median":-135.748112,"eighty":-53.902639,"marketCap":128594895322},{"date":"2026-08-28","current":697.321291,"twenty":-236.422847,"median":-135.694724,"eighty":-52.683151,"marketCap":122977832050}],"updateTime":1788210646578},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06990\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1183127454","title":"Movement Alert｜Kelun-Biotech Biopharmaceutical Rises 3.07% in Regular Trading, Nomura Raises Target Price to HK$544.42 on Encouraging Phase III ADC Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1183127454","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183127454?lang=en_us&edition=fundamental","pubTime":"2026-05-27 13:46","pubTimestamp":1779860782,"startTime":"0","endTime":"0","summary":"On May 27, Kelun-Biotech Biopharmaceutical rose 3.07% in regular trading, trading at 477.8 HKD/share, with trading volume of approximately 130 million HKD.On the news front, Nomura recently raised...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116262705","title":"Movement Alert｜Kelun-Biotech Biopharmaceutical Rises 3.12% in Regular Trading, ASCO Annual Meeting Data Continues to Catalyze Pipeline Value Reassessment","url":"https://stock-news.laohu8.com/highlight/detail?id=1116262705","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116262705?lang=en_us&edition=fundamental","pubTime":"2026-05-26 10:20","pubTimestamp":1779762011,"startTime":"0","endTime":"0","summary":"On May 26, Kelun-Biotech Biopharmaceutical rose 3.12% in regular trading, trading at 484.0 HKD/share, with trading volume of approximately 189 million HKD.On the news front, the company has seen a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637143983","title":"Kelun Biotech to Present Study Results of Cancer Drugs at American Oncology Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2637143983","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637143983?lang=en_us&edition=fundamental","pubTime":"2026-05-22 20:41","pubTimestamp":1779453682,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical  will present the results of its registrational studies on sacituzumab tirumotecan  and lunbotinib fumarate at the 2026 American Society of Clinical Oncology annual meeting, according to a filing by parent Sichuan Kelun Pharmaceutical  with the Shenzhen bourse.Its study on its sacituzumab tirumotecan drug versus pembrolizumab for advanced non-small cell lung cancer treatment showed a higher response rate for its sac-TMT against pembrolizumab, the filing said.The company will also present results from its study on lunbotinib, which showed an objective response rate of 87.1% on patients with RET-fusion positive non-small cell lung cancer in patients with prior chemotherapy.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AFG","002422","BK1161","BK4107","BK4585","BK4588","BK4581","BK0060","06990","BK4117","LU0196878994.USD","LU1064131003.USD","LU1979443071.USD","LU1064130708.USD","XBI","LU2148510915.USD","BK0239","LU1934453819.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106210458","title":"SKB BIO Receives \"Buy\" Rating from China Post Securities on Anticipated Global Pipeline Value Realization","url":"https://stock-news.laohu8.com/highlight/detail?id=1106210458","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106210458?lang=en_us&edition=fundamental","pubTime":"2026-05-22 17:20","pubTimestamp":1779441659,"startTime":"0","endTime":"0","summary":"China Post Securities released a research report stating that SKB BIO (06990) is an innovative drug R&D company entering a harvest period as its clinical maturity advances. The firm forecasts company...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161027","06990","BK1161","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637602043","title":"BUZZ-Sichuan Kelun-Biotech at 4-week high on positive lung cancer trial with Merck","url":"https://stock-news.laohu8.com/highlight/detail?id=2637602043","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637602043?lang=en_us&edition=fundamental","pubTime":"2026-05-22 13:07","pubTimestamp":1779426431,"startTime":"0","endTime":"0","summary":"BUZZ-Sichuan Kelun-Biotech at 4-week high on positive lung cancer trial with Merck** Hong Kong shares of Sichuan Kelun-Biotech Biopharmaceutical 6990.HK jump 10.1% to HK$499.6, their highest level since April 22** Stock of key shareholder Sichuan Kelun Pharmaceutical 002422.SZ surge 9.8% to 35.57 yuan, highest point since April 17** Sichuan Kelun-Biotech said on Thursday its experimental treatment combined with partner Merck's MRK.N Keytruda improved progression-free survival in patients with advanced lung cancer, meeting the main goal of a late-stage study** The trial tested the drug, sacituzumab tirumotecan or sac-TMT, in combination with cancer therapy Keytruda as a first-line treatment for patients with advanced non-small cell lung cancer, against Keytruda alone** YTD, Hong Kong stock up 20.9%, shares of Shenzhen-listed parent up 19.4%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nL1N41Z04B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","IE00BLSP4239.USD","LU2324357040.USD","LU2112291526.USD","LU0070302665.USD","LU0130517989.USD","SGXZ57979304.SGD","LU0196878994.USD","LU1430594728.SGD","LU2023250843.SGD","LU0098860793.USD","LU1037948897.HKD","LU1979443071.USD","BK0239","LU0211331839.USD","002422","LU0965509283.SGD","LU1934455863.HKD","LU2125909247.SGD","IE00B1BXHZ80.USD","LU1934453819.USD","IE00BJJMRZ35.SGD","LU1291159041.SGD","LU0106261372.USD","LU0208291251.USD","LU1066053197.SGD","MRK","SG9999013999.USD","SG9999014559.SGD","SG9999015358.SGD","IE000M9KFDE8.USD","LU0130102774.USD","LU1989772923.USD","LU1035773651.USD","SG9999014542.SGD","LU0985320562.USD","LU1974910355.USD","LU1941712264.USD","LU2125909593.SGD","LU0648001328.SGD","LU0859254822.USD","LU2125154778.USD","LU1064130708.USD","LU2148510915.USD","LU2491049909.HKD","LU1116320901.HKD","LU1069347547.HKD","LU2491050071.SGD","LU0320765489.SGD","LU0265550359.USD","IE00BJT1NW94.SGD","SG9999014575.USD","LU1093756168.USD","LU2106854487.HKD","LU0203347892.USD","BK4559","SG9999001176.SGD","LU2461242641.AUD","LU0203345920.USD","LU0942090050.USD","IE00BLSP4452.SGD","LU1066051498.USD","LU0861579265.USD","BK4585","LU0980610538.SGD","LU0477156953.USD","SG9999014567.USD","LU2433249047.HKD","LU1057294990.SGD","LU2023250504.SGD","LU2361044949.HKD","LU1037948541.HKD","BK4007","LU1116320737.USD","LU0266013472.USD","SG9999002232.USD","LU1066051225.USD","IE00BSNM7G36.USD","LU1585245621.USD","BK4516","BK4533","LU1571399168.USD","LU0868494617.USD","LU2491050154.USD","LU0265550946.USD","BK4550","LU0122379950.USD","LU1989772840.SGD","LU0238689110.USD","LU2125154935.USD","IE00BN8TJ469.HKD","06990","LU1023059063.AUD","LU2361044865.SGD","LU0058720904.USD","LU1699723380.USD","SG9999015341.SGD","LU1934455194.USD","IE0002141913.USD","BK0060","IE00B4R5TH58.HKD","LU0234572021.USD","LU0320765646.SGD","LU0965509010.AUD","SG9999001176.USD","LU0006306889.USD","LU2361045086.USD","LU1093756325.SGD","LU1989771016.USD","LU0432979614.USD","LU1929549753.HKD","SG9999002224.SGD","LU0965509101.SGD","BK1161","LU1923622614.USD","LU0965508806.USD","LU1941712348.USD","LU2360032135.SGD","LU1064131003.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU1983299246.USD","LU2357627491.SGD","IE00B2B36J28.USD","LU1934455277.USD","LU1066051811.HKD","LU1162221912.USD","BK4588","LU0868494708.USD","LU1917777945.USD","IE00BBT3K403.USD","LU2468319806.SGD","LU2089984988.USD","LU0289739699.SGD","SG9999001440.SGD","LU1061106388.HKD","LU1201861249.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150750988","title":"Movement Alert｜Kelun-Biotech Biopharmaceutical Rises 7.58% in Regular Trading, ASCO Oral Presentations and Phase III Lung Cancer Trial Success Drive Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1150750988","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150750988?lang=en_us&edition=fundamental","pubTime":"2026-05-22 09:37","pubTimestamp":1779413829,"startTime":"0","endTime":"0","summary":"On May 22, Kelun-Biotech Biopharmaceutical rose 7.58% in regular trading, trading at 478.0 HKD/share, with trading volume of approximately 153 million HKD.On the news front, the company announced it...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113175618","title":"Stock Track | SKB BIO Soars 5.16% at Open on Positive Phase III Lung Cancer Data and ASCO Presentation News","url":"https://stock-news.laohu8.com/highlight/detail?id=1113175618","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113175618?lang=en_us&edition=fundamental","pubTime":"2026-05-22 09:31","pubTimestamp":1779413484,"startTime":"0","endTime":"0","summary":"SKB BIO's stock price surged 5.16% at the open on Friday, driven by multiple positive clinical development and regulatory updates from the biopharmaceutical company.The company announced that its...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183196023","title":"Movement Alert｜Kelun-Biotech Biopharmaceutical Rises 5.34% at Open, ASCO Oral Presentations and Multiple Phase III Successes Drive Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1183196023","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183196023?lang=en_us&edition=fundamental","pubTime":"2026-05-22 09:24","pubTimestamp":1779413063,"startTime":"0","endTime":"0","summary":"On May 22, Kelun-Biotech Biopharmaceutical rose 5.34% at open, trading at 477.8 HKD/share, with trading volume of approximately 5.86 million HKD.On the news front, the company announced it will...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164172096","title":"SKB BIO Highlights Robust Sac-TMT Phase III and Lunbotinib Phase II Data Ahead of ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1164172096","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164172096?lang=en_us&edition=fundamental","pubTime":"2026-05-22 07:43","pubTimestamp":1779406990,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) will release results from three oncology programs at the American Society of Clinical Oncology (ASCO) Annual Meeting, 29 May–2 June 2026,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154215999","title":"SKB BIO (06990) to Present Multiple Innovative Drug Research Findings at 2026 ASCO Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1154215999","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154215999?lang=en_us&edition=fundamental","pubTime":"2026-05-22 07:41","pubTimestamp":1779406889,"startTime":"0","endTime":"0","summary":"SKB BIO (06990) announced that the company will present multiple company-led clinical research results at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held from May 29...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","BK1574","06990","LU0196878994.USD","BK1161","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637368292","title":"Sichuan Kelun-Biotech Biopharmaceutical Co Ltd - Nda for Lunbotinib Fumarate Accepted for Review by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2637368292","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637368292?lang=en_us&edition=fundamental","pubTime":"2026-05-22 07:31","pubTimestamp":1779406263,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nFWN41Y148:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","LU0196878994.USD","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637350835","title":"BRIEF-Kelun-Biotech's Sac-TMT + Pembrolizumab Improves Survival In Late-Stage China Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2637350835","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637350835?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:03","pubTimestamp":1779397430,"startTime":"0","endTime":"0","summary":"BRIEF-Kelun-Biotech's Sac-TMT + Pembrolizumab Improves Survival In Late-Stage China TrialMay 22  - Sichuan Kelun-Biotech Biopharmaceutical Co Ltd 6990.HK:SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL-SAFETY PROFILE OF SAC-TMT + PEMBROLIZUMAB GENERALLY MANAGEABLE, CONSISTENT WITH SAFETY PROFILE OF COMPONENTSSICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL: SACITUZUMAB TIRUMOTECAN + PEMBROLIZUMAB EXTENDED PFS VERSUS PEMBROLIZUMAB ALONE IN PHASE 3 LUNG CANCER TRIALSICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL: OBJECTIVE RESPONSE RATE 70.2% WITH SAC-TMT PLUS PEMBROLIZUMAB VERSUS 42.0% WITH PEMBROLIZUMAB ALONEFurther company coverage: 6990.HK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nP8N3Z60BM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002232.USD","BK4585","LU2491050154.USD","BK4559","SG9999002224.SGD","SG9999014575.USD","LU1291159041.SGD","LU1093756168.USD","IE0002141913.USD","LU0203345920.USD","LU0965509101.SGD","LU1069347547.HKD","LU0098860793.USD","LU1023059063.AUD","LU1066053197.SGD","LU1989772840.SGD","LU2324357040.USD","BK4516","LU0432979614.USD","LU0965508806.USD","SG9999001440.SGD","LU0965509010.AUD","LU1057294990.SGD","IE00BBT3K403.USD","LU1929549753.HKD","LU1037948541.HKD","BK4534","LU1941712264.USD","LU1974910355.USD","LU0234572021.USD","BK4533","LU1983299246.USD","LU1585245621.USD","LU2125154778.USD","IE00BJT1NW94.SGD","LU0266013472.USD","LU2023250843.SGD","LU1571399168.USD","BK4550","LU0211331839.USD","LU2461242641.AUD","LU0130102774.USD","LU0868494617.USD","LU1066051498.USD","LU0122379950.USD","LU0861579265.USD","LU1066051225.USD","BK1161","IE00BSNM7G36.USD","IE00B2B36J28.USD","SG9999013999.USD","LU1934455277.USD","LU0265550359.USD","LU2491050071.SGD","LU0196878994.USD","SG9999015358.SGD","LU0130517989.USD","IE00BFTCPJ56.SGD","LU2361045086.USD","SG9999014542.SGD","IE00BLSP4239.USD","LU0070302665.USD","LU1093756325.SGD","LU0203347892.USD","LU0058720904.USD","IE000M9KFDE8.USD","LU2360032135.SGD","LU0648001328.SGD","IE00B4R5TH58.HKD","LU1941712348.USD","LU0208291251.USD","SGXZ57979304.SGD","LU0980610538.SGD","LU0965509283.SGD","LU0868494708.USD","LU1201861249.SGD","SG9999001176.SGD","LU2433249047.HKD","SG9999014567.USD","BK4007","IE00BJJMRZ35.SGD","LU0320765646.SGD","LU1116320901.HKD","LU0289739699.SGD","LU0477156953.USD","IE00B1BXHZ80.USD","LU2357627491.SGD","LU2106854487.HKD","LU2125154935.USD","LU0106261372.USD","LU0942090050.USD","LU0985320562.USD","LU1061106388.HKD","06990","LU2125909593.SGD","LU1037948897.HKD","LU2125909247.SGD","LU1934455863.HKD","LU1989772923.USD","LU1035773651.USD","IE00BLSP4452.SGD","LU0320765489.SGD","LU1116320737.USD","LU2089984988.USD","LU0238689110.USD","LU2491049909.HKD","LU1162221912.USD","SG9999014559.SGD","LU0006306889.USD","LU2468319806.SGD","LU1699723380.USD","LU1934455194.USD","LU0859254822.USD","LU0265550946.USD","SG9999015341.SGD","SG9999001176.USD","LU2023250504.SGD","LU1917777945.USD","LU2361044865.SGD","LU2361044949.HKD","LU1430594728.SGD","LU1066051811.HKD","LU1989771016.USD","LU2112291526.USD","IE00BN8TJ469.HKD","IE0009355771.USD","BK4588","LU1923622614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637352029","title":"Sichuan Kelun-Biotech Biopharmaceutical: Sacituzumab Tirumotecan + Pembrolizumab Extended Pfs VS Pembrolizumab Alone in Phase 3 Lung Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2637352029","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637352029?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:03","pubTimestamp":1779397429,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nP8N3Z60BM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0203347892.USD","LU1035773651.USD","SG9999002224.SGD","SG9999014567.USD","LU1934455863.HKD","LU2491049909.HKD","LU1066053197.SGD","LU1989771016.USD","LU1974910355.USD","IE0002141913.USD","LU0265550359.USD","IE00BBT3K403.USD","IE00BLSP4452.SGD","LU0861579265.USD","LU0432979614.USD","LU0985320562.USD","LU0070302665.USD","LU0648001328.SGD","LU2106854487.HKD","LU1069347547.HKD","SG9999013999.USD","IE00B1BXHZ80.USD","LU0320765489.SGD","IE0009355771.USD","LU0868494617.USD","LU1923622614.USD","BK4533","LU0965509010.AUD","LU2361045086.USD","LU1066051225.USD","LU0122379950.USD","IE00BLSP4239.USD","LU1061106388.HKD","LU1934455277.USD","002422","SG9999015358.SGD","LU2357627491.SGD","BK4534","LU0477156953.USD","LU0006306889.USD","LU0266013472.USD","IE00B4R5TH58.HKD","LU0238689110.USD","BK1161","LU1430594728.SGD","LU0965509101.SGD","LU2324357040.USD","IE00BJJMRZ35.SGD","BK4007","LU0289739699.SGD","LU1934455194.USD","SGXZ57979304.SGD","LU2468319806.SGD","LU0980610538.SGD","BK4585","BK4516","LU0965508806.USD","LU0965509283.SGD","LU1929549753.HKD","LU1571399168.USD","IE00BFTCPJ56.SGD","SG9999001176.SGD","LU1116320737.USD","LU1093756325.SGD","BK4559","LU0211331839.USD","LU1585245621.USD","LU2125909247.SGD","LU2125154935.USD","SG9999014575.USD","LU1066051498.USD","BK4550","LU2125909593.SGD","LU2491050071.SGD","LU1201861249.SGD","LU2361044865.SGD","IE00BN8TJ469.HKD","LU0130102774.USD","LU1699723380.USD","LU2112291526.USD","IE00BJT1NW94.SGD","LU1917777945.USD","LU2491050154.USD","LU0196878994.USD","LU1037948541.HKD","LU1037948897.HKD","LU0098860793.USD","SG9999001440.SGD","LU1162221912.USD","LU1291159041.SGD","LU2461242641.AUD","LU1983299246.USD","LU2023250843.SGD","LU0130517989.USD","LU1057294990.SGD","LU2361044949.HKD","LU1989772923.USD","SG9999014542.SGD","LU0320765646.SGD","SG9999014559.SGD","IE00B2B36J28.USD","LU1023059063.AUD","LU1941712348.USD","LU0058720904.USD","LU1066051811.HKD","SG9999002232.USD","LU0942090050.USD","LU2360032135.SGD","LU2023250504.SGD","SG9999015341.SGD","LU0208291251.USD","SG9999001176.USD","LU2125154778.USD","LU0265550946.USD","LU1116320901.HKD","LU2433249047.HKD","LU0859254822.USD","LU0868494708.USD","LU0106261372.USD","LU1941712264.USD","LU1989772840.SGD","LU0234572021.USD","06990","LU2089984988.USD","LU0203345920.USD","IE000M9KFDE8.USD","IE00BSNM7G36.USD","LU1093756168.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637352025","title":"Sichuan Kelun-Biotech Biopharmaceutical-Safety Profile of Sac-TMT + Pembrolizumab  Generally Manageable, Consistent With Safety Profile of Components","url":"https://stock-news.laohu8.com/highlight/detail?id=2637352025","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637352025?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:03","pubTimestamp":1779397429,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nP8N3Z60BM:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1934455194.USD","BK4550","LU0868494708.USD","LU0320765489.SGD","LU2023250504.SGD","LU1093756325.SGD","LU2491050154.USD","LU1941712264.USD","LU1291159041.SGD","LU0965509283.SGD","LU1989772923.USD","LU1934455863.HKD","LU0965509101.SGD","LU0130102774.USD","IE00BBT3K403.USD","LU1934455277.USD","IE0002141913.USD","LU1941712348.USD","LU1069347547.HKD","LU2357627491.SGD","LU2491050071.SGD","SG9999013999.USD","LU0980610538.SGD","LU1917777945.USD","BK4533","BK4559","SGXZ57979304.SGD","IE00BJT1NW94.SGD","LU2491049909.HKD","LU1057294990.SGD","SG9999001176.SGD","LU2324357040.USD","LU1037948541.HKD","SG9999014567.USD","LU1093756168.USD","LU0196878994.USD","LU0238689110.USD","IE00B4R5TH58.HKD","LU2468319806.SGD","LU0985320562.USD","LU0234572021.USD","SG9999002232.USD","LU1989771016.USD","IE000M9KFDE8.USD","IE00B1BXHZ80.USD","BK1161","LU0289739699.SGD","LU0868494617.USD","LU0203347892.USD","LU1066053197.SGD","LU2125154935.USD","LU0122379950.USD","LU2360032135.SGD","IE0009355771.USD","LU1974910355.USD","06990","LU0070302665.USD","LU1923622614.USD","LU2433249047.HKD","LU2361044949.HKD","IE00BLSP4239.USD","LU0432979614.USD","LU2125909593.SGD","LU0942090050.USD","LU2361044865.SGD","BK4585","BK4588","SG9999002224.SGD","LU0098860793.USD","LU1116320901.HKD","LU0477156953.USD","LU0320765646.SGD","LU1023059063.AUD","LU2125154778.USD","LU0211331839.USD","LU1162221912.USD","LU2125909247.SGD","IE00BN8TJ469.HKD","LU0648001328.SGD","LU0058720904.USD","BK4516","LU1430594728.SGD","LU0861579265.USD","LU1066051811.HKD","LU0130517989.USD","IE00BSNM7G36.USD","LU0208291251.USD","MRK","IE00BFTCPJ56.SGD","LU0965509010.AUD","LU1929549753.HKD","LU2089984988.USD","SG9999014559.SGD","LU0203345920.USD","LU1585245621.USD","IE00BJJMRZ35.SGD","BK4534","SG9999014542.SGD","LU2106854487.HKD","IE00B2B36J28.USD","LU0106261372.USD","LU0006306889.USD","LU1061106388.HKD","LU0265550359.USD","SG9999015341.SGD","LU2023250843.SGD","LU2461242641.AUD","IE00BLSP4452.SGD","LU0266013472.USD","LU1035773651.USD","LU1066051498.USD","LU1201861249.SGD","LU0265550946.USD","LU0965508806.USD","LU2361045086.USD","LU1066051225.USD","LU1571399168.USD","SG9999001440.SGD","LU1116320737.USD","SG9999014575.USD","LU1037948897.HKD","LU2112291526.USD","SG9999015358.SGD","LU1699723380.USD","LU1983299246.USD","LU0859254822.USD","SG9999001176.USD","LU1989772840.SGD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637520023","title":"Kelun, Merck's lung cancer combo improves survival in late-stage China trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2637520023","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637520023?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:02","pubTimestamp":1779397340,"startTime":"0","endTime":"0","summary":"Kelun, Merck's lung cancer combo improves survival in late-stage China trialMay 21 (Reuters) - Sichuan Kelun-Biotech Biopharmaceutical 6990.HK said on Thursday its experimental treatment combined with","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nL4N41Y24Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","LU1267930490.SGD","LU2491050154.USD","LU1430594728.SGD","BK4533","LU1487256676.USD","LU2106854487.HKD","LU0390134368.USD","LU1084165304.USD","LU2108987350.USD","LU2360032135.SGD","SG9999014567.USD","LU1153585028.USD","LU0526926950.USD","LU1974910355.USD","LU0997586515.USD","LU2539964713.USD","LU0106261372.USD","BK4534","LU0345777659.USD","LU0827474353.SGD","LU1301847155.USD","LU1196032939.SGD","LU0980610538.SGD","LU0006306889.USD","LU0823399737.USD","LU1267930573.SGD","LU2125909247.SGD","LU2133065610.SGD","LU1273509221.SGD","LU1496350502.SGD","LU2361045086.USD","LU0965509283.SGD","LU1699723380.USD","SG9999001176.SGD","SG9999013999.USD","LU0029864427.USD","LU0208291251.USD","SG9999001176.USD","LU1923622614.USD","LU0211331839.USD","LU1934455863.HKD","LU0960981461.USD","LU1069347547.HKD","LU0310800965.SGD","LU1064130708.USD","SG9999015341.SGD","LU1934455277.USD","LU0130517989.USD","LU0310799852.SGD","LU2089283258.USD","LU1037948897.HKD","SG9999014542.SGD","LU0920783379.SGD","LU2237443465.HKD","LU0114720955.EUR","IE0034235188.USD","LU1066051225.USD","LU1078025761.USD","LU1170363599.USD","LU1585245621.USD","LU1019634622.SGD","LU0859254822.USD","LU1267930813.SGD","LU0708994859.HKD","LU2293690082.USD","LU0889566641.SGD","LU1917777945.USD","LU1003076772.USD","LU0965509010.AUD","LU1104425308.USD","LU1153584641.USD","SG9999002224.SGD","LU1481600234.SGD","LU2293690249.USD","LU0171276677.USD","LU1880407132.USD","LU1355424745.HKD","LU0887340254.USD","LU2112291526.USD","LU1035773651.USD","LU1066051811.HKD","LU0058720904.USD","LU1064131003.USD","LU1941712264.USD","LU0158827948.USD","SGXZ57979304.SGD","LU0784385170.HKD","LU0098860793.USD","LU2023250843.SGD","LU1061106388.HKD","IE000M9KFDE8.USD","SG9999014559.SGD","LU0553294199.USD","LU0130102774.USD","LU0972486137.USD","LU2468319806.SGD","MRK","LU0985320562.USD","LU0265550359.USD","IE00BLSP4452.SGD","LU0640478417.SGD","LU0868494617.USD","LU1057294990.SGD","IE00BN8TJ469.HKD","LU0957799991.USD","LU0545039389.USD","LU0949170426.SGD","LU1941712348.USD","SG9999002232.USD","LU2237443549.SGD","LU1989772840.SGD","BK4585","BK1161","LU0861579265.USD","LU0011850046.USD","LU1880407215.USD","LU0234572021.USD","LU2237443895.HKD","LU1989772923.USD","BK4588","IE0009355771.USD","LU0203345920.USD","LU2357627491.SGD","LU0949170772.SGD","LU0128525689.USD","LU2125154778.USD","LU1496350171.SGD","LU2114397693.USD","LU1323610961.USD","IE00BJT1NW94.SGD","LU0857590862.USD","LU0784383803.USD","LU0047473722.SGD","LU2148510915.USD","LU1291159041.SGD","IE00BLSP4239.USD","LU0496365809.HKD","BK4516","LU0122379950.USD","LU0575583348.USD","LU0997586432.USD","LU1119994496.HKD","SG9999001440.SGD","LU0203347892.USD","LU0882574055.USD","LU0969580561.USD","LU0345777147.USD","LU1979443071.USD","LU1037948541.HKD","LU0238689110.USD","LU1201861249.SGD","LU0266013472.USD","LU2461242641.AUD","LU0289739699.SGD","LU0784384876.USD","LU1093756168.USD","LU2091194634.USD","LU0964806797.USD","LU2491049909.HKD","LU1019632923.USD","LU2125909593.SGD","LU0648001328.SGD","LU1051770623.HKD","LU2361044865.SGD","IE00B3T34201.USD","LU1934453819.USD","LU0757432116.USD","LU0792757196.USD","LU2237443382.USD","IE00B2B36J28.USD","IE0002141913.USD","LU0077335932.USD","LU1015430645.USD","LU1116320737.USD","LU0211326755.USD","BK0239","LU0211326839.USD","LU1066053197.SGD","LU1571399168.USD","LU1116320901.HKD","IE00B4R5TH58.HKD","LU1023059063.AUD","LU1929549753.HKD","LU0920840948.USD","LU1989771016.USD","LU2324357040.USD","LU1046234339.USD","LU2361044949.HKD","IE00B1BXHZ80.USD","LU0171293334.USD","LU0889565080.SGD","03165","06990","LU0265550946.USD","LU0047473722.EUR","LU0738911758.USD","LU0868494708.USD","LU2023250504.SGD","LU2023251221.USD","BK4559","LU0784385840.USD","LU0211327993.USD","BK5011","LU0499090636.EUR","LU0976567544.SGD","LU1162221912.USD","LU0557290698.USD","LU1983299246.USD","LU0823416689.USD","LU0128525929.USD","LU2279689827.SGD","IE00BBT3K403.USD","IE00BSNM7G36.USD","LU1814569148.SGD","LU2237443978.SGD","LU0432979614.USD","LU0310800379.SGD","LU0070302665.USD","SG9999015358.SGD","LU1003077747.HKD","LU2355687059.USD","LU0965508806.USD","LU1261432733.SGD","LU2089984988.USD","BK4550","LU1481599808.USD","LU0211328371.USD","BK4007","LU1093756325.SGD","IE00BKPKM643.USD","LU2125154935.USD","LU0320765646.SGD","IE00BJJMRZ35.SGD","LU2237443622.USD","BK0060","LU0963555726.SGD","LU1064927863.SGD","LU2433249047.HKD","LU1066051498.USD","LU2089284900.SGD","IE00BFTCPJ56.SGD","LU0942090050.USD","LU1267930227.SGD","SG9999014575.USD","LU0477156953.USD","LU2491050071.SGD","LU0965509101.SGD","LU1934455194.USD","LU0052756011.USD","LU0661504455.SGD","LU0320765489.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637133490","title":"Kelun-Biotech says sac-TMT beats chemotherapy in Phase III first-line TNBC PFS","url":"https://stock-news.laohu8.com/highlight/detail?id=2637133490","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637133490?lang=en_us&edition=fundamental","pubTime":"2026-05-21 22:05","pubTimestamp":1779372321,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical reported a prespecified interim analysis showing its Phase III OptiTROP-Breast03 study of sacituzumab tirumotecan met the primary endpoint of delaying disease worsening versus chemotherapy as a first-line treatment for unresectable locally recurrent or metastatic triple-negative breast cancer.Overall survival results have not been presented in a mature form yet, with a favorable trend seen so far.No new safety issues emerged, supporting continued development in the first-line setting.The readout positions the drug for potential label expansion beyond its existing China approval in later-line triple-negative breast cancer, with regulatory discussions planned with China’s drug regulator on next steps.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL7R5dDh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","BK1161","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121194992","title":"SKB BIO Shares Surge Over 5% on Positive Phase III Results for TROP2 ADC Developed with Merck","url":"https://stock-news.laohu8.com/highlight/detail?id=1121194992","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121194992?lang=en_us&edition=fundamental","pubTime":"2026-05-21 11:05","pubTimestamp":1779332707,"startTime":"0","endTime":"0","summary":"SKB BIO (06990) rose more than 5%. As of press time, the stock was up 3.3%, trading at HK$451.4 with a turnover of HK$166 million. Recently, according to an announcement from SKB BIO, Merck announced...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4239.USD","LU1571399168.USD","BK4007","LU1934455863.HKD","LU1989772840.SGD","SG9999013999.USD","LU2361044865.SGD","IE00BFTCPJ56.SGD","BK4134","LU0203347892.USD","LU0980610538.SGD","LU2112291526.USD","LU0432979614.USD","LU2491049909.HKD","LU0859254822.USD","LU1093756325.SGD","LU1923622614.USD","SGXZ57979304.SGD","LU1162221912.USD","LU1934455194.USD","LU1430594728.SGD","IE00BBT3K403.USD","LU2125909247.SGD","SG9999001440.SGD","LU0965509283.SGD","LU2125909593.SGD","LU0265550359.USD","LU2089984988.USD","LU2125154935.USD","IE00B4R5TH58.HKD","LU2491050071.SGD","SG9999015341.SGD","LU0868494708.USD","MRK","LU0289739699.SGD","IE0009355771.USD","LU0098860793.USD","LU0196878994.USD","LU1941712348.USD","LU1037948541.HKD","LU1989771016.USD","SG9999002232.USD","LU0265550946.USD","LU2357627491.SGD","LU2023250504.SGD","LU1699723380.USD","BK4080","BK4588","LU0006306889.USD","LU0211331839.USD","LU0861579265.USD","LU2461242641.AUD","LU1941712264.USD","LU0965508806.USD","BK1161","BK4585","LU0477156953.USD","LU1066051225.USD","BK4516","LU1035773651.USD","LU0234572021.USD","SG9999015358.SGD","SG9999014567.USD","LU2361045086.USD","LU1066053197.SGD","LU1929549753.HKD","IE0002141913.USD","IE00BJJMRZ35.SGD","06990","LU1934455277.USD","IE00B1BXHZ80.USD","SG9999014559.SGD","LU2361044949.HKD","LU0965509010.AUD","LU1037948897.HKD","LU1989772923.USD","BK4550","BK4231","LU0203345920.USD","SG9999014542.SGD","LU0965509101.SGD","LU2491050154.USD","BK4533","LU1201861249.SGD","LU0130102774.USD","IE00B2B36J28.USD","LU2324357040.USD","LU1116320737.USD","LU1291159041.SGD","LU1061106388.HKD","SG9999014575.USD","LU0058720904.USD","LU0106261372.USD","LU0985320562.USD","BK4559","IE00BN8TJ469.HKD","LU0208291251.USD","LU1057294990.SGD","LU0238689110.USD","IE000M9KFDE8.USD","LU2468319806.SGD","LU0130517989.USD","LU1069347547.HKD","SG9999001176.USD","LU1023059063.AUD","SG9999002224.SGD","LU1974910355.USD","BK4534","LU0648001328.SGD","LU2023250843.SGD","IE00BJT1NW94.SGD","IE00BLSP4452.SGD","LU1066051498.USD","LU0868494617.USD","LU2433249047.HKD","SG9999001176.SGD","LU2106854487.HKD","LU0122379950.USD","LU0320765646.SGD","LU2125154778.USD","LU1983299246.USD","LU2360032135.SGD","LU0320765489.SGD","LU0070302665.USD","LU1116320901.HKD","IE00BSNM7G36.USD","LU0942090050.USD","LU1093756168.USD","LU1585245621.USD","LU0266013472.USD","LU1917777945.USD","LU1066051811.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133296679","title":"Stock Track | SKB BIO Soars 5.22% Intraday on Positive Phase III Trial Results and Regulatory Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1133296679","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133296679?lang=en_us&edition=fundamental","pubTime":"2026-05-21 09:54","pubTimestamp":1779328497,"startTime":"0","endTime":"0","summary":"SKB BIO's stock surged 5.22% during intraday trading on Thursday, driven by positive clinical developments and regulatory progress.The rally was fueled by Merck's announcement that sacituzumab...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107878773","title":"Movement Alert｜Kelun-Biotech Biopharmaceutical Rises 3.52% in Regular Trading, TROP2 ADC Phase III Trial Achieves Dual Primary Endpoints in Endometrial Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1107878773","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107878773?lang=en_us&edition=fundamental","pubTime":"2026-05-21 09:52","pubTimestamp":1779328366,"startTime":"0","endTime":"0","summary":"On May 21, Kelun-Biotech Biopharmaceutical rose 3.52% in regular trading, trading at 454.6 HKD/share, with trading volume of approximately 51.11 million HKD. The rally was driven by continued...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636899669","title":"A Look At Sichuan Kelun-Biotech Biopharmaceutical’s (SEHK:6990) Valuation After New Oncology Regulatory Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2636899669","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636899669?lang=en_us&edition=fundamental","pubTime":"2026-05-20 08:40","pubTimestamp":1779237629,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) is back in focus after fresh oncology pipeline news, including priority review for sacituzumab tirumotecan in lung cancer and clinical trial approval for bispecific antibody SKB118 in advanced solid tumors.\nSee our latest analysis for Sichuan Kelun-Biotech Biopharmaceutical.\nThese oncology updates come after a mixed stretch for the stock. A 1-day share price return of 1.27% lifted the HK$429.6 quote, but the 30-day share price return is down...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/a-look-at-sichuan-kelun-biotech-biopharmaceuticals-sehk6990","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/a-look-at-sichuan-kelun-biotech-biopharmaceuticals-sehk6990","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","LU0196878994.USD","06990","BK1161","XBI","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}